[1]
I. Ivanova, “Immune-mediated Arthritis after Treatment with Nivolumab in a Patient with Malignant Melanoma”, Rheumatol Bul, vol. 34, no. 1, pp. 77–89, May 2026, doi: 10.35465/szed3p23.